Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 40-46

  Avila, J L ^a   Rojas, M ^a   Avila, A ^a  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

Autoimmunity; Chagas' disease; Cholesterol sulphate antibodies; Sterols antibody

Indexed keywords

AUTOANTIBODY; CHOLESTEROL SULFATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; POLYLYSINE; STEROL;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHAGAS DISEASE; COMPLICATION; CONTROLLED STUDY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

EID: 0030066629     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.877569.x     Document Type: Article

References (34)

1. Hudson L. Autoimmune phenomena in chronic chagasic cardiopathy. Parasitology Today 1985; 1:6-9.
2. Petry K, Eisen H. Chagas disease: a model for the study of autoimmune diseases. Parasitol Today 1989; 5:111-6.
3. Alcantara FG. Desnervaçâo dos gânglios cardiacos intramurais e cervicotorȧcicos na molestia de Chagas. Revta Goaiana Med 1970; 16:159-77.
4. Köberle F. Die chronische Chagaskardiopathie. Virchows Arch Path Anat Physiol 1957; 330:267-95.
5. Tafuri WL. Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am J Trop Med Hyg 1970; 19:405-17.
6. Köberle F. Pathogenesis of Chagas disease. Ciba Fdn Symp 1974; 20:137-58.
7. Brandao HJS, Zulian R. Nerve cell depopulation in chronic Chagas' disease. A quantitative study in the cerebelum. Rev Inst Med Trop Sao Paulo 1966; 8:281-6.
8. Avila JL. Molecular mimicry between Trypanosoma cruzi and host nervous tissues. In: Chagas' disease and the nervous system. PAHO Scientific Publ 547; 1994:268-92.
9. Van Voorhis WC, Schlekewy L, Trong HL. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci USA 1991; 88:5993-7.
10. Wood JN, Hudson L, Jessell TM et al. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurons and Trypanosoma cruzi parasites. Nature 1982; 296:34-38.
11. Ribeiro dos Santos R, Marquez JO, Furtado CCG et al. Antibodies against neurons in chronic Chagas' disease. Tropenmed Parasit 1979; 30:19-23.
12. Unterkircher C, Avrameas S, Ternynck T. Autoantibodies in the sera of Trypanosoma cruzi-infected individuals with or without clinical Chagas disease. J Clin Lab Anal 1993; 7:60-69.
13. Avila JL, Rojas M, Towbin H. Serological activity against galactosyl (α1-3)galactose in sera from patients with several Kinetoplastida infections. J Clin Microbiol 1988; 26:126-31.
14. Avila JL, Rojas M, Carrasco H et al. Characterization of a natural human antibody with anti-Galactosyl(α1-2)Galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection. Amer J Trop Med Hyg 1992; 47:413-21.
15. Petry K, Nudelman E, Eisen H et al. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol Biochem Parasitol 1988; 30:113-22.
16. Towbin H, Rosenfelder G, Wieslander J et al. Circulating antibodies to mouse laminin in Chagas' disease, American cutaneous leishmaniasis and normal individuals recognize terminal galactosyl (α1-3)galactose epitopes. J Exp Med 1987; 166:419-32.
17. Goin JC, Borda E, Perez-Leiros C et al. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Sys 1994; 47:45-52.
18. Beach DH, Goad JL, Holtz GG Jr. Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes. Biochem Biophys Res Commun 1986; 136:851-6.
19. Iwamori M, Moser HW, Kishimoto Y. Cholesterol sulfate in rat tissues. Tissue distribution, developmental change and brain subcellular localization. Biochim Biophys Acta 1976; 441:268-79.
20. Avila JL, Rojas M, Rieber M. Antibodies to laminin in American cutaneous leishmaniasis. Infect Immun 1984; 43:402-6.
21. Avila JL, Rojas M, Carrasco H. Increased galactosyl(α1-3) galactose antibody levels in patients with different clinical stages of tropical chronic dilatatory cardiomyopathies. Immunol (Life Sci Adv) 1991; 10:1-10.
22. Avila JL, Rojas M, Velazquez-Avila G et al. Antibodies to laminin in Trypanosoma rangeli-infected subjects. Parasitol Res 1987; 73:178-9.
23. Avila JL, Rojas M, Garcia L. Persistence of elevated levels of galactosyl(α1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis. J Clin Microbiol 1988; 26:1842-7.
24. Avila JL, Rojas M, Carrasco H. Elevated levels of antibodies against sulphatide are present in all chronic chagasic and dilated cardiomyopathy sera. Clin Exp Immunol 1993; 92:460-5.
25. Avila JL, Bretaña A, Casanova MA et al. Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites. Exp Parasitol 1979; 48:27-35.
26. Piras MM, Piras R, Henriquez D. Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol 1982; 6:67-81.
27. Galili U, Macher BA, Buehler J et al. Human natural anti-α-galactosyl IgG, II. Specific recognition of α (1-3)-linked galactose residues. J Exp Med 1985; 162:573-9.
28. Avila JL, Rojas M. Elevated cerebroside antibody levels in human visceral and cutaneous leishmaniasis, Trypanosoma rangeli infection, and chronic Chagas' disease. Am J Trop Med Hyg 1990; 43:52-60.
29. Alving CR, Swartz GM, Wassef NM. Naturally occurring autoantibodies to cholesterol in humans. Biochem Soc Trans 1989; 17:637-40.
30. Shichijo S, Alving CR. Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes. Biochim Biophys Acta 1986; 858:118-24.
31. Ternynck T, Bleux C, Gregoire J et al. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J Immunol 1990; 144:1504-11.
32. Kahn S, Kahn M, Eisen H. Polyreactive autoantibodies to negatively charged epitopes following Trypanosoma cruzi infection. Eur J Immunol 1992; 22:3051-6.
33. Dighiero G, Lymberi P, Holmberg D et al. High frequency of natural antibodies in normal newborn mice. J Immunol 1985; 134:765-71.
34. Sica REP. Peripheral and central nervous system alterations in Chagas' disease. In: Chagas' disease and the nervous system. PAHO Scientific Publ 547; 1994; 184-201.